Cancer Cells Go Incognito to Cause Therapy Relapse

$ 16.99

4.9
(383)
In stock
Description

Dormant cancer cells and dysfunctional immune cells living together in a tumor niche form a therapy-resistant reservoir.

Cancer stem cell in prostate cancer progression, metastasis and therapy resistance - ScienceDirect

Biomolecules, Free Full-Text

Cancer Immunotherapy News, Articles

CAR T-Cell Therapy Earns Indication for Lymphoma in First Relapse

Niki Spahich, PhD Author Profile, The Scientist Magazine®

Chris Klebanoff, oncologist: 'We have to take a much more precise view towards how we treat each cancer patient', Science

INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia - Transplantation and Cellular Therapy, Official Publication of the American

Cancer Immunotherapy News, Articles

Full article: Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium